Identification of a New Equid Herpesvirus 1 DNA Polymerase (ORF30) Genotype with the Isolation of a C2254/H752 Strain in French Horses Showing no Major Impact on the Strain Behaviour

Gabrielle Sutton (1, 2) , Côme Thieulent (1, 2) , Christine Fortier (1, 2, 3) , Erika Hue (1, 2, 3) , Christel Marcillaud-Pitel (4) , Alexis Pléau (5) , Alain Deslis (5) , Edouard Guitton (5) , Romain Paillot (1, 2, 6) , Stéphane Pronost (1, 2)

1 LABÉO - LABÉO, Pôle d’analyses et de recherche de Normandie
2 BIOTARGEN - Biologie, génétique et thérapies ostéoarticulaires et respiratoires
3 ImpedanCELL
4 RESPE - Réseau d'Epidémio-Surveillance en Pathologie Équine
5 PFIE - Plateforme d'Infectiologie Expérimentale
6 School of Equine and Veterinary Physiotherapy

Equid herpesvirus 1 is one of the most common viral pathogens in the horse population and is associated with respiratory disease, abortion and still-birth, neonatal death and neurological disease. A single point mutation in the DNA polymerase gene (ORF30: A2254G, N752D) has been widely associated with neuropathogenicity of strains, although this association has not been exclusive. This study describes the fortuitous isolation of a strain carrying a new genotype C2254 (H752) from an outbreak in France that lasted several weeks in 2018 and involved 82 horses, two of which showed neurological signs of disease. The strain was characterised as UL clade 10 using the equid herpesvirus 1 (EHV-1) multi-locus sequence typing (MLST) classification but has not been identified or isolated since 2018. The retrospective screening of EHV-1 strains collected between 2016 and 2018 did not reveal the presence of the C2254 mutation. When cultured in vitro, the C2254 EHV-1 strain induced a typical EHV-1 syncytium and cytopathic effect but no significant difference was observed when compared with A2254 and G2254 EHV-1 strains. An experimental infection was carried out on four Welsh mountain ponies to confirm the infectious nature of the C2254 strain. A rapid onset of marked respiratory disease lasting at least 2 weeks, with significant virus shedding and cell-associated viraemia, was observed. Finally, an in vitro antiviral assay using impedance measurement and viral load quantification was performed with three antiviral molecules (ganciclovir (GCV), aciclovir (ACV) and aphidicolin (APD)) on the newly isolated C2254 strain and two other A/G2254 field strains. The three strains showed similar sensitivity to ganciclovir and aphidicolin but both C2254 and A2254 strains were more sensitive to aciclovir than the G2254 strain, based on viral load measurement.

Mots clés: equid herpesvirus 1; DNA polymerase; ORF30; EHV-1; antivirals; experimental infection

Domaines: Virologie; Systématique, phylogénie et taxonomie; Médecine vétérinaire et santé animale

Gabrielle Sutton, Côme Thieulent, Christine Fortier, Erika Hue, Christel Marcillaud-Pitel, et al.. Identification of a New Equid Herpesvirus 1 DNA Polymerase (ORF30) Genotype with the Isolation of a C2254/H752 Strain in French Horses Showing no Major Impact on the Strain Behaviour. Viruses, 2020, 12 (10), 23 p. ⟨10.3390/v12101160⟩. ⟨hal-02971415⟩